The present study finds that BRD7 is a novel host factor to synergize with EBV in regulating cellular and viral genomes, successfully conquering EBV latent-lytic switch via targeting c-Myc in BL cells (Fig. 9). This evidence concerns the gene BRD7 and Burkitt lymphoma.